Treating thrombotic thrombocytopenic purpura without plasma exchange during the COVID-19 pandemic. A case report and a brief literature review

We report the case of a patient diagnosed with a clinical relapse of acquired immune-mediated thrombotic thrombocytopenic purpura (TTP) who was successfully treated with low-dose rituximab plus corticosteroids without the use of plasma exchange (PEx), which was unavailable at the time due to the COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Galindo-Calvillo, César David, Rodríguez-Roque, Carlos Saúl, Gómez-De León, Andrés, Tarín-Arzaga, Luz, Gómez-Almaguer, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912363/
https://www.ncbi.nlm.nih.gov/pubmed/33714651
http://dx.doi.org/10.1016/j.transci.2021.103107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912363/
https://www.ncbi.nlm.nih.gov/pubmed/33714651
http://dx.doi.org/10.1016/j.transci.2021.103107

Ejemplares similares